Animal Health Firm IPO Soars (ZTS)

Zoetis Inc. (NYSE: ZTS), a spin-off of the animal health business of Pfizer Inc. (NYSE: PFE), held its initial public offering this morning. The...

Merck's Diarrhea Drug Could be First in 30 Years

A Merck-licensed drug to fight a bacteria blamed for increasing rates of deadly diarrhea in hospitals and nursing homes was found to cut repeat infections by 72%. The drug reduces the risk of re-infection by the bug and its more virulent new strain more than in patients taking only antibiotics.